Literature DB >> 21532556

Innovative drug R&D in China.

Jingzong Qi, Qingli Wang, Zhenhang Yu, Xin Chen, Fengshan Wang.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21532556     DOI: 10.1038/nrd3435

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  Life sciences venture capital in emerging markets.

Authors:  Justin Chakma; Stephen M Sammut; Ajay Agrawal
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

2.  A proposed definition of rare diseases for China: from the perspective of return on investment in new orphan drugs.

Authors:  Yazhou Cui; Jinxiang Han
Journal:  Orphanet J Rare Dis       Date:  2015-03-07       Impact factor: 4.123

3.  Obstacles and opportunities in Chinese pharmaceutical innovation.

Authors:  Jingyun Ni; Junrui Zhao; Carolina Oi Lam Ung; Yuanjia Hu; Hao Hu; Yitao Wang
Journal:  Global Health       Date:  2017-03-24       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.